首页 > 最新文献

Current Dermatology Reports最新文献

英文 中文
Emerging Fungal Infections and Cutaneous Manifestations in Immunosuppressed Patients 免疫抑制患者的新发真菌感染和皮肤表现
IF 1.6 Q2 DERMATOLOGY Pub Date : 2023-04-05 DOI: 10.1007/s13671-023-00386-9
J. Varghese, S. Guhan, Lida Zheng
{"title":"Emerging Fungal Infections and Cutaneous Manifestations in Immunosuppressed Patients","authors":"J. Varghese, S. Guhan, Lida Zheng","doi":"10.1007/s13671-023-00386-9","DOIUrl":"https://doi.org/10.1007/s13671-023-00386-9","url":null,"abstract":"","PeriodicalId":10838,"journal":{"name":"Current Dermatology Reports","volume":"12 1","pages":"69 - 81"},"PeriodicalIF":1.6,"publicationDate":"2023-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45334575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Compression Therapy in Dermatology 皮肤科的压迫疗法
IF 1.6 Q2 DERMATOLOGY Pub Date : 2023-03-31 DOI: 10.1007/s13671-023-00388-7
M. Romanelli, Flavia Manzo Margiotta, Alessandra Michelucci, G. Granieri, A. Janowska, V. Dini
{"title":"Compression Therapy in Dermatology","authors":"M. Romanelli, Flavia Manzo Margiotta, Alessandra Michelucci, G. Granieri, A. Janowska, V. Dini","doi":"10.1007/s13671-023-00388-7","DOIUrl":"https://doi.org/10.1007/s13671-023-00388-7","url":null,"abstract":"","PeriodicalId":10838,"journal":{"name":"Current Dermatology Reports","volume":"12 1","pages":"33 - 37"},"PeriodicalIF":1.6,"publicationDate":"2023-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49330447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Lessons Learned from Anatomic Susceptibility in Vitiligo Patients: A Systematic Review 从白癜风患者的解剖学易感性中吸取的经验教训:一项系统综述
IF 1.6 Q2 DERMATOLOGY Pub Date : 2023-03-17 DOI: 10.1007/s13671-023-00384-x
Parsa Abdi, H. Maibach, Christopher Farkouh, R. Law, Christian Awad
{"title":"Lessons Learned from Anatomic Susceptibility in Vitiligo Patients: A Systematic Review","authors":"Parsa Abdi, H. Maibach, Christopher Farkouh, R. Law, Christian Awad","doi":"10.1007/s13671-023-00384-x","DOIUrl":"https://doi.org/10.1007/s13671-023-00384-x","url":null,"abstract":"","PeriodicalId":10838,"journal":{"name":"Current Dermatology Reports","volume":"12 1","pages":"82 - 91"},"PeriodicalIF":1.6,"publicationDate":"2023-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48455707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Hypersensitivity to Implanted Metal Devices 对植入金属装置过敏
IF 1.6 Q2 DERMATOLOGY Pub Date : 2023-01-31 DOI: 10.1007/s13671-023-00381-0
B. Schwartz, D. Pithadia, Jennifer K. Chen
{"title":"Hypersensitivity to Implanted Metal Devices","authors":"B. Schwartz, D. Pithadia, Jennifer K. Chen","doi":"10.1007/s13671-023-00381-0","DOIUrl":"https://doi.org/10.1007/s13671-023-00381-0","url":null,"abstract":"","PeriodicalId":10838,"journal":{"name":"Current Dermatology Reports","volume":"12 1","pages":"8 - 22"},"PeriodicalIF":1.6,"publicationDate":"2023-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47116903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges in Textile Contact Dermatitis 纺织品接触性皮炎面临的挑战
IF 1.6 Q2 DERMATOLOGY Pub Date : 2023-01-25 DOI: 10.1007/s13671-023-00383-y
S. Nedorost
{"title":"Challenges in Textile Contact Dermatitis","authors":"S. Nedorost","doi":"10.1007/s13671-023-00383-y","DOIUrl":"https://doi.org/10.1007/s13671-023-00383-y","url":null,"abstract":"","PeriodicalId":10838,"journal":{"name":"Current Dermatology Reports","volume":"12 1","pages":"1 - 7"},"PeriodicalIF":1.6,"publicationDate":"2023-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44958551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient Satisfaction in Teledermatology: an Updated Review. 远程皮肤科患者满意度:最新综述。
IF 1.6 Q2 DERMATOLOGY Pub Date : 2023-01-01 DOI: 10.1007/s13671-023-00382-z
Sueheidi Santiago, Jun Lu

Purpose of review: Teledermatology continues to gain popularity across the world. It is crucial that dermatologists understand patient experience and satisfaction to effectively incorporate this practice into patient care. This article provides an updated review of recent findings on patient satisfaction in teledermatology.

Recent findings: Over the last 2 years, there has been an increase in studies on the patient experience of live-video teledermatology, while previous studies largely focused on store-and-forward teledermatology. This reflects the expansion of live-video teledermatology since the COVID-19 pandemic. Patients are generally very satisfied with both store-and-forward and live-video teledermatology, valuing its accessibility, quality of care, and patient-provider relationship. Decreased patient satisfaction is linked to technical difficulties, privacy concerns, lack of procedure availability, and thorough physical exams. However, teledermatology experiences are not equal across demographic groups. Access to technical support, digital literacy, age, social economic status, and type of dermatological conditions have all been found to affect patient experience.

Summary: Studies show high levels of patient satisfaction in teledermatology but limitations exist. Future efforts to improve teledermatology experiences will require reducing barriers among demographics, improving patient education, investment in technology, and collaboration among all parties involved.

综述目的:远程皮肤病学在世界范围内越来越受欢迎。至关重要的是,皮肤科医生了解患者的经验和满意度,有效地将这种做法纳入患者护理。这篇文章提供了一个最新的审查,最近发现的患者满意度在远程皮肤科。最近的发现:在过去的两年里,关于实时视频远程皮肤科的患者体验的研究有所增加,而以前的研究主要集中在存储转发远程皮肤科。这反映了自2019冠状病毒病大流行以来实时视频远程皮肤科的扩展。患者通常对存储转发和实时视频远程皮肤科非常满意,重视其可及性、护理质量和医患关系。患者满意度的下降与技术困难、隐私问题、缺乏程序可用性和彻底的身体检查有关。然而,远程皮肤科的经验在不同的人群中是不平等的。获得技术支持、数字素养、年龄、社会经济地位和皮肤病类型都被发现会影响患者的体验。摘要:研究表明,远程皮肤科的患者满意度很高,但存在局限性。未来改善远程皮肤科治疗体验的努力将需要减少人口统计学障碍、改善患者教育、技术投资以及所有相关方之间的合作。
{"title":"Patient Satisfaction in Teledermatology: an Updated Review.","authors":"Sueheidi Santiago,&nbsp;Jun Lu","doi":"10.1007/s13671-023-00382-z","DOIUrl":"https://doi.org/10.1007/s13671-023-00382-z","url":null,"abstract":"<p><strong>Purpose of review: </strong>Teledermatology continues to gain popularity across the world. It is crucial that dermatologists understand patient experience and satisfaction to effectively incorporate this practice into patient care. This article provides an updated review of recent findings on patient satisfaction in teledermatology.</p><p><strong>Recent findings: </strong>Over the last 2 years, there has been an increase in studies on the patient experience of live-video teledermatology, while previous studies largely focused on store-and-forward teledermatology. This reflects the expansion of live-video teledermatology since the COVID-19 pandemic. Patients are generally very satisfied with both store-and-forward and live-video teledermatology, valuing its accessibility, quality of care, and patient-provider relationship. Decreased patient satisfaction is linked to technical difficulties, privacy concerns, lack of procedure availability, and thorough physical exams. However, teledermatology experiences are not equal across demographic groups. Access to technical support, digital literacy, age, social economic status, and type of dermatological conditions have all been found to affect patient experience.</p><p><strong>Summary: </strong>Studies show high levels of patient satisfaction in teledermatology but limitations exist. Future efforts to improve teledermatology experiences will require reducing barriers among demographics, improving patient education, investment in technology, and collaboration among all parties involved.</p>","PeriodicalId":10838,"journal":{"name":"Current Dermatology Reports","volume":"12 1","pages":"23-26"},"PeriodicalIF":1.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880362/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9260740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
The Impact of Immune-Modulating Treatments for Dermatological Diseases on the Risk of Infection with SARS-CoV-2 and Outcomes Associated with COVID-19 Illness. 皮肤病免疫调节治疗对感染SARS-CoV-2的风险和与新冠肺炎疾病相关的结果的影响。
IF 2.4 Q2 DERMATOLOGY Pub Date : 2023-01-01 Epub Date: 2023-04-03 DOI: 10.1007/s13671-023-00385-w
Nicole Maynard, April W Armstrong

Purpose of review: Immune-modulating treatments are used in dermatology for a variety of conditions. The authors aim to review the data regarding the safety of these treatments during the COVID-19 pandemic, namely the risk of infection with SARS-CoV-2 and the outcomes associated with COVID-19-related illness.

Recent findings: Several large-scale studies found no increased risk of COVID-19 infection for patients on TNF-α inhibitors, IL-17 inhibitors, IL-12/23 inhibitors, IL-23 inhibitors, dupilumab, and methotrexate. They also found that these patients did not have worse outcomes when infected with COVID-19. The data regarding JAK inhibitors, rituximab, prednisone, cyclosporine, mycophenolate mofetil, and azathioprine are more mixed.

Summary: Based on current research and guidelines from the American Academy of Dermatology and the National Psoriasis Foundation, dermatology patients on immune-modulating therapies can continue treatment during the COVID-19 pandemic when they are not infected with SARS-CoV-2. For patients who have COVID-19, guidelines encourage individualized assessment of the benefits and risks of continuing or temporarily withholding treatment.

综述目的:免疫调节治疗在皮肤科用于各种疾病。作者旨在审查新冠肺炎大流行期间这些治疗的安全性数据,即感染SARS-CoV-2的风险和与新冠肺炎相关疾病相关的结果。最近的发现:几项大规模研究发现,使用TNF-α抑制剂、IL-17抑制剂、IL-12/23抑制剂、IL-23抑制剂、dupilumab和甲氨蝶呤的患者感染新冠肺炎的风险没有增加。他们还发现,这些患者在感染新冠肺炎时并没有出现更糟糕的结果。关于JAK抑制剂、利妥昔单抗、泼尼松、环孢菌素、霉酚酸酯和硫唑嘌呤的数据更为混杂。摘要:根据美国皮肤病学会和国家牛皮癣基金会的最新研究和指南,在新冠肺炎大流行期间,接受免疫调节疗法的皮肤病患者如果没有感染SARS-CoV-2,可以继续治疗。对于患有新冠肺炎的患者,指南鼓励对继续或暂时停止治疗的益处和风险进行个性化评估。
{"title":"The Impact of Immune-Modulating Treatments for Dermatological Diseases on the Risk of Infection with SARS-CoV-2 and Outcomes Associated with COVID-19 Illness.","authors":"Nicole Maynard, April W Armstrong","doi":"10.1007/s13671-023-00385-w","DOIUrl":"10.1007/s13671-023-00385-w","url":null,"abstract":"<p><strong>Purpose of review: </strong>Immune-modulating treatments are used in dermatology for a variety of conditions. The authors aim to review the data regarding the safety of these treatments during the COVID-19 pandemic, namely the risk of infection with SARS-CoV-2 and the outcomes associated with COVID-19-related illness.</p><p><strong>Recent findings: </strong>Several large-scale studies found no increased risk of COVID-19 infection for patients on TNF-α inhibitors, IL-17 inhibitors, IL-12/23 inhibitors, IL-23 inhibitors, dupilumab, and methotrexate. They also found that these patients did not have worse outcomes when infected with COVID-19. The data regarding JAK inhibitors, rituximab, prednisone, cyclosporine, mycophenolate mofetil, and azathioprine are more mixed.</p><p><strong>Summary: </strong>Based on current research and guidelines from the American Academy of Dermatology and the National Psoriasis Foundation, dermatology patients on immune-modulating therapies can continue treatment during the COVID-19 pandemic when they are not infected with SARS-CoV-2. For patients who have COVID-19, guidelines encourage individualized assessment of the benefits and risks of continuing or temporarily withholding treatment.</p>","PeriodicalId":10838,"journal":{"name":"Current Dermatology Reports","volume":"12 2","pages":"45-55"},"PeriodicalIF":2.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068706/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9992427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pityriasis Lichenoides Following SARS-CoV-2 Infection/Vaccination. SARS-CoV-2感染/接种后的地衣样糠疹。
IF 1.6 Q2 DERMATOLOGY Pub Date : 2023-01-01 DOI: 10.1007/s13671-023-00380-1
Aileen M Feschuk, Maxwell Green, Nadia Kashetsky, Howard I Maibach

Purpose of review: Pityriasis lichenoides (PL) is a spectrum of dermatological conditions involving polymorphous lesions. Natural history of the condition ranges from acute to chronic. Cases of PL following SARS-CoV-2 infection/vaccination have been reported, but not yet comprehensively reviewed. Hence, the objective of this article is to review and summarize cases of PL following SARS-CoV-2 infection/vaccination in order to guide clinicians in its diagnosis and management.

Recent findings: PubMed, Embase, and Web of Science were searched for relevant articles. Thirteen articles, consisting of 14 cases of PL following SARS-CoV-2 infection/vaccination, were identified. Males represented 64.3% of cases, and the average age of those affected was 41.4 years. The majority of cases (N = 9, 64.3%) were following SARS-CoV-2 vaccination, the most commonly implicated being Pfizer-BioNTech (n = 8/10, 80%), while four (28.6) followed infection. The overall latency period ranged from 5 days to 1 month. Treatments varied greatly. However, at the time of follow-up, 12/14 patients (85.7%) had either marked improvement or complete resolution of lesions.

Summary: This review cannot determine causality. However, a temporal association was observed with the case reports, and one case of PL followed SARS-CoV-2 infection and recurred with subsequent vaccination, suggesting an association. Nevertheless, risk of developing PL following SARS-CoV-2 infection/vaccination is likely extremely low. There is also the possibility these cases are purely coincidental. Still, clinicians should be aware of this possible etiology when diagnosing a new or exacerbated case of PL. Finally, given that the majority of patients had marked improvement or complete resolution of lesions at the time of follow-up, clinicians should provide reassurance to their affected patients.

综述目的:苔藓样糠疹(PL)是一种涉及多形态病变的皮肤病。此病的自然病程从急性到慢性不等。已报告了SARS-CoV-2感染/疫苗接种后的PL病例,但尚未全面审查。因此,本文的目的是回顾和总结SARS-CoV-2感染/接种后的PL病例,以指导临床医生对其进行诊断和管理。最近的发现:PubMed, Embase和Web of Science搜索相关文章。共发现13篇文章,包括14例SARS-CoV-2感染/接种后的PL病例。男性占64.3%,平均年龄为41.4岁。大多数病例(N = 9, 64.3%)接种了SARS-CoV-2疫苗,最常见的是辉瑞- biontech (N = 8/10, 80%),而4例(28.6%)感染了SARS-CoV-2疫苗。总的潜伏期从5天到1个月不等。治疗方法差别很大。然而,在随访时,12/14的患者(85.7%)有明显改善或病变完全消退。摘要:本综述不能确定因果关系。然而,在病例报告中观察到一种时间相关性,1例PL是在SARS-CoV-2感染后发生的,并在随后接种疫苗后复发,这表明一种相关性。然而,在SARS-CoV-2感染/接种疫苗后发生PL的风险可能极低。也有可能这些案例纯属巧合。尽管如此,在诊断新的或加重的PL病例时,临床医生应该意识到这种可能的病因。最后,鉴于大多数患者在随访时病变有明显改善或完全消退,临床医生应该向受影响的患者提供保证。
{"title":"Pityriasis Lichenoides Following SARS-CoV-2 Infection/Vaccination.","authors":"Aileen M Feschuk,&nbsp;Maxwell Green,&nbsp;Nadia Kashetsky,&nbsp;Howard I Maibach","doi":"10.1007/s13671-023-00380-1","DOIUrl":"https://doi.org/10.1007/s13671-023-00380-1","url":null,"abstract":"<p><strong>Purpose of review: </strong>Pityriasis lichenoides (PL) is a spectrum of dermatological conditions involving polymorphous lesions. Natural history of the condition ranges from acute to chronic. Cases of PL following SARS-CoV-2 infection/vaccination have been reported, but not yet comprehensively reviewed. Hence, the objective of this article is to review and summarize cases of PL following SARS-CoV-2 infection/vaccination in order to guide clinicians in its diagnosis and management.</p><p><strong>Recent findings: </strong>PubMed, Embase, and Web of Science were searched for relevant articles. Thirteen articles, consisting of 14 cases of PL following SARS-CoV-2 infection/vaccination, were identified. Males represented 64.3% of cases, and the average age of those affected was 41.4 years. The majority of cases (<i>N</i> = 9, 64.3%) were following SARS-CoV-2 vaccination, the most commonly implicated being Pfizer-BioNTech (<i>n</i> = 8/10, 80%), while four (28.6) followed infection. The overall latency period ranged from 5 days to 1 month. Treatments varied greatly. However, at the time of follow-up, 12/14 patients (85.7%) had either marked improvement or complete resolution of lesions.</p><p><strong>Summary: </strong>This review cannot determine causality. However, a temporal association was observed with the case reports, and one case of PL followed SARS-CoV-2 infection and recurred with subsequent vaccination, suggesting an association. Nevertheless, risk of developing PL following SARS-CoV-2 infection/vaccination is likely extremely low. There is also the possibility these cases are purely coincidental. Still, clinicians should be aware of this possible etiology when diagnosing a new or exacerbated case of PL. Finally, given that the majority of patients had marked improvement or complete resolution of lesions at the time of follow-up, clinicians should provide reassurance to their affected patients.</p>","PeriodicalId":10838,"journal":{"name":"Current Dermatology Reports","volume":"12 1","pages":"27-32"},"PeriodicalIF":1.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844164/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10279694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology of Hidradenitis Suppurativa: Current Status 化脓性Hidradenitis的流行病学现状
IF 1.6 Q2 DERMATOLOGY Pub Date : 2022-10-11 DOI: 10.1007/s13671-022-00372-7
Diana Díaz, Alejandra Rivera, Valentina Otero, L. Rueda
{"title":"Epidemiology of Hidradenitis Suppurativa: Current Status","authors":"Diana Díaz, Alejandra Rivera, Valentina Otero, L. Rueda","doi":"10.1007/s13671-022-00372-7","DOIUrl":"https://doi.org/10.1007/s13671-022-00372-7","url":null,"abstract":"","PeriodicalId":10838,"journal":{"name":"Current Dermatology Reports","volume":"11 1","pages":"336-340"},"PeriodicalIF":1.6,"publicationDate":"2022-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49288233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Tattoo-Related Allergic Contact Dermatitis 纹身相关过敏性接触性皮炎
IF 1.6 Q2 DERMATOLOGY Pub Date : 2022-10-06 DOI: 10.1007/s13671-022-00371-8
K. Daftary, W. Liszewski
{"title":"Tattoo-Related Allergic Contact Dermatitis","authors":"K. Daftary, W. Liszewski","doi":"10.1007/s13671-022-00371-8","DOIUrl":"https://doi.org/10.1007/s13671-022-00371-8","url":null,"abstract":"","PeriodicalId":10838,"journal":{"name":"Current Dermatology Reports","volume":"1 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2022-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44265885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Dermatology Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1